Preclinical Efficacy of VTX-0811: A Humanized First-in-Class PSGL-1 Mab Targeting TAMs to Suppress Tumor Growth
Cancers(2024)
Key words
PSGL-1,macrophage,immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined